The latest stereotactic body
radiotherapy treatments (SBRT) for
prostate and advanced lung
cancer
are being delivered significantly faster than before thanks to the
latest radiotherapy instrumentation. For lung SBRT, treatment delivery
times are down to less than two minutes on average, which is good news
for patients.
Latest Stereotactic Body Treatment - Versa HD

Designed
in close collaboration with clinicians, the new instrumentation called
Versa HD provides advanced radiotherapy techniques that enable high
precision treatment in managing a range of cancers in the head and neck,
lung, breast and prostate. It has the ability to continually reshape
the
radiation beam to the fine contours of the
tumour so a higher dose of radiation can be delivered.
Cancer Centre London
(part of Aspen Healthcare) will be the first oncology provider in
London to use Versa HD, which will come into service at the centre later
in the year. Aspen Healthcare CEO, Des Shiels, says: “Cancer Centre
London (part of Aspen Healthcare) is delighted to announce a major
investment in its radiotherapy service provision as part of its
commitment to delivering the highest standards of care to its patients.
Cancer Centre London will be the first oncology provider in London to
have Elekta’s Versa HD linear accelerator."
Cancer Centre London
Cancer Centre London is widely acknowledged as a ‘Centre of
Excellence’ that attracts expertise from recognised leaders within the
medical profession. Its dedicated and responsive radiotherapy team (of
Consultant Clinical Oncologists, Radiographers, Clinical Scientists and
other healthcare professionals), provides a personalized and
evidence-based radiotherapy service that ensures the highest standards
of patient care are maintained throughout the course of a patient's
treatment.
No comments:
Post a Comment